ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery

Mark Loganoff, MD, shared his experience and perspective on the benefits and realities of transitioning to office-based surgery in an interview with the Eye Care Network at the 2025 American Society of Cataract and Refractive Surgery annual meeting, held April 25 to 28 in Los Angeles, California. “What first drew me to office-based surgery (OBS) was the ability to really have more control over the OR environment,” Loganoff began, highlighting key advantages such as selecting preferred technologies, optimizing case turnover, and customizing staff training to deliver a premium, patient-centric experience.

Loganoff emphasized the importance of creating a “white glove” experience, particularly for patients receiving premium lenses. Training in-house staff and minimizing downtime were central to this model. He also praised the patient experience, noting, “I think the oral-based sedation, not having to poke someone with an IV—no sticks—takes a little of the fear away.” This shift, he explained, not only benefits patients but also enhances surgeon satisfaction.

A major draw for Loganoff was the switch from IV to oral sedation. “Oral sedation is one of the things that really enticed me about office-based surgery,” he said. He cited logistical efficiencies—eliminating vein access issues and unnecessary preoperative medical visits—as well as improved patient comfort. Recalling his first day operating in the new OBS center, Loganoff admitted, “I was terrified… And to my pleasant surprise, it’s better. Patients like oral-based sedation better.”

He addressed common concerns among peers, especially regarding efficacy and reimbursement. “Am I going to be able to operate with just oral-based sedation? …Absolutely,” he assured. As for financial viability, he offered reassurance: “You will get reimbursed for your cases. You will see a good profit from this.”